Skip to main content
Microbot Medical Inc. logo

Microbot Medical Inc. — Investor Relations & Filings

Ticker · MBOT ISIN · US59503A2042 LEI · 549300AEUNO16KTJXD72 US Manufacturing
Open in API
Filings indexed 1,062 across all filing types
Latest filing 2020-06-19 Board/Management Inform…
Country US United States of America
Listing US MBOT

About Microbot Medical Inc.

http://www.microbotmedical.com/

Microbot Medical Inc. is a commercial-stage medical device company focused on transforming endovascular procedures with advanced robotic technology. The company researches, designs, and develops robotic endoluminal surgery devices for the minimally invasive surgery market. Its flagship product, the LIBERTY® Endovascular Robotic System, is the first single-use, remotely operated robotic solution designed to provide physicians with enhanced precision, control, and efficiency. Developed in collaboration with experts in Interventional Radiology, Neuroradiology, and Cardiology, the system aims to improve patient care and physician safety.

Recent filings

Filing Released Lang Actions
Board/Management Information 2020
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is the resignation of a board member, Yoav Waizer, effective June 30, 2020. This is an announcement of a change in the company's board of directors. The document does not contain financial statements or detailed financial data, nor is it an earnings release or annual report. It specifically relates to management changes, which fits the category of Board/Management Information (MANG). The document length is 3248 characters, which is typical for an 8-K filing announcing management changes. Therefore, the correct classification is MANG with high confidence.
2020-06-19 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q1 2020
2020-05-15 English
Director's Dealing 2020
Director's Dealing
2020-05-07 English
Board/Management Information 2020
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The key content is the appointment of a new Chief Medical Officer, which is a change in senior management. The document does not contain financial statements or detailed financial analysis, so it is not an Annual Report (10-K) or Interim Report (IR). It is not an earnings release or any other financial report. The primary focus is on management change, specifically the appointment of a new officer. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3148 characters, which is consistent with a typical 8-K filing for management changes. Confidence is high due to the clear mention of appointment of a principal officer and the use of Form 8-K for such announcements.
2020-05-07 English
Annual Report 2019
Annual Report FY 2019
2020-04-29 English
Annual Report 2019
Annual Report FY 2019
2020-04-14 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.